Efficacy of Adding Oral Amisulpride to Dual Prophylaxis for Postoperative Nausea and Vomiting in Patients at High Risk for Nausea and Vomiting Undergoing Gynecological Surgery
Conditions
- Post Operative Nausea and Vomiting (PONV)
Interventions
- DRUG: Encapsulated amisulpride 50 mg (matched for color, weight, smell and size)
- DRUG: Encapsulated placebo (matched for color, weight, smell and size)
Sponsor
Instituto do Cancer do Estado de São Paulo
Collaborators